PCSK9 and familial hyperaldosteronism: (1) PCSK9 Inhibitors. PCSK9 is a protein involved in regulating LDLR recycling, and it was discovered when investigators found gain-of-function genetic alterations in PCSK9 protein in patients with FH [218].